AstraZeneca Unusual Options Activity

Someone with a lot of money to spend has taken a bullish stance on AstraZeneca AZN.

And retail traders should know.

We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with AZN, it often means somebody knows something is about to happen.

So how do we know what this whale just did?

Today, Benzinga's options scanner spotted 10 uncommon options trades for AstraZeneca.

This isn't normal.

The overall sentiment of these big-money traders is split between 50% bullish and 50%, bearish.

Out of all of the special options we uncovered, 6 are puts, for a total amount of $208,496, and 4 are calls, for a total amount of $140,708.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $62.5 to $77.5 for AstraZeneca over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AstraZeneca's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AstraZeneca's whale trades within a strike price range from $62.5 to $77.5 in the last 30 days.

AstraZeneca Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
AZN PUT SWEEP NEUTRAL 06/16/23 $75.00 $54.6K 2.0K 268
AZN PUT TRADE BULLISH 10/20/23 $72.50 $45.2K 367 0
AZN CALL SWEEP BEARISH 10/20/23 $62.50 $42.6K 285 15
AZN CALL SWEEP NEUTRAL 01/19/24 $75.00 $35.0K 1.5K 0
AZN CALL SWEEP BULLISH 06/16/23 $77.50 $33.3K 4.7K 137

Where Is AstraZeneca Standing Right Now?

  • With a volume of 1,403,043, the price of AZN is down -0.13% at $74.63.
  • RSI indicators hint that the underlying stock may be approaching overbought.
  • Next earnings are expected to be released in 77 days.

What The Experts Say On AstraZeneca:

  • Argus Research has decided to maintain their Buy rating on AstraZeneca, which currently sits at a price target of $85.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for AstraZeneca, Benzinga Pro gives you real-time options trades alerts.


Analyst Ratings




Posted In: OptionsMarketsBZI-UOA